BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20189477)

  • 1. T cells use rafts for survival.
    Stone JD; Kranz DM
    Immunity; 2010 Feb; 32(2):145-7. PubMed ID: 20189477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. For T cell receptors, some breakups might not last forever.
    Govern CC; Chakraborty AK
    Immunity; 2010 Feb; 32(2):141-2. PubMed ID: 20189475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the structural basis of T-cell costimulation.
    Bajorath J
    J Mol Graph Model; 2000 Apr; 18(2):176-9. PubMed ID: 10994522
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
    Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
    Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
    Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
    Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered peptide ligands of islet autoantigen Imogen 38 inhibit antigen specific T cell reactivity in human type-1 diabetes.
    Geluk A; van Meijgaarden KE; Roep BO; Ottenhoff TH
    J Autoimmun; 1998 Aug; 11(4):353-61. PubMed ID: 9776713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rafting MHC-II domains in the APC (presynaptic) plasma membrane and the thresholds for T-cell activation and immunological synapse formation.
    Gombos I; Detre C; Vámosi G; Matkó J
    Immunol Lett; 2004 Mar; 92(1-2):117-24. PubMed ID: 15081535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of lipid rafts in T cells.
    Thomas S; Kumar RS; Brumeanu TD
    Arch Immunol Ther Exp (Warsz); 2004; 52(4):215-24. PubMed ID: 15467486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T cell receptor-dependent regulation of lipid rafts controls naive CD8+ T cell homeostasis.
    Cho JH; Kim HO; Surh CD; Sprent J
    Immunity; 2010 Feb; 32(2):214-26. PubMed ID: 20137986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired TCR signaling through dysfunction of lipid rafts in sphingomyelin synthase 1 (SMS1)-knockdown T cells.
    Jin ZX; Huang CR; Dong L; Goda S; Kawanami T; Sawaki T; Sakai T; Tong XP; Masaki Y; Fukushima T; Tanaka M; Mimori T; Tojo H; Bloom ET; Okazaki T; Umehara H
    Int Immunol; 2008 Nov; 20(11):1427-37. PubMed ID: 18820264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costimulation and endogenous MHC ligands contribute to T cell recognition.
    Wülfing C; Sumen C; Sjaastad MD; Wu LC; Dustin ML; Davis MM
    Nat Immunol; 2002 Jan; 3(1):42-7. PubMed ID: 11731799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
    Wu LC; Tuot DS; Lyons DS; Garcia KC; Davis MM
    Nature; 2002 Aug; 418(6897):552-6. PubMed ID: 12152083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered collagen II peptides inhibited T-cell activation in rheumatoid arthritis.
    Li R; Li X; Li Z
    Clin Immunol; 2006; 118(2-3):317-23. PubMed ID: 16343992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered T and B lymphocyte signaling pathways in lupus.
    Peng SL
    Autoimmun Rev; 2009 Jan; 8(3):179-83. PubMed ID: 18721908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inner side of T cell lipid rafts.
    Gri G; Molon B; Manes S; Pozzan T; Viola A
    Immunol Lett; 2004 Jul; 94(3):247-52. PubMed ID: 15275973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The multiple mechanisms of T cell receptor cross-reactivity.
    Yin Y; Mariuzza RA
    Immunity; 2009 Dec; 31(6):849-51. PubMed ID: 20064442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M; Weth R; Wels WS
    J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC restriction: slip-sliding away.
    Wilson IA; Stanfield RL
    Nat Immunol; 2005 May; 6(5):434-5. PubMed ID: 15843798
    [No Abstract]   [Full Text] [Related]  

  • 19. Activation thresholds determine susceptibility to peptide-induced tolerance in a heterogeneous myelin-reactive T cell repertoire.
    McCue D; Ryan KR; Wraith DC; Anderton SM
    J Neuroimmunol; 2004 Nov; 156(1-2):96-106. PubMed ID: 15465600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global analysis of dynamic changes in lipid raft proteins during T-cell activation.
    Kobayashi M; Katagiri T; Kosako H; Iida N; Hattori S
    Electrophoresis; 2007 Jun; 28(12):2035-43. PubMed ID: 17486660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.